Related Experiment Video
Updated: Jun 17, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Penicillin allergy delabeling practices and barriers across SHEA research network US institutions: a cross-sectional
Kap Sum Foong1, Rachel Erdil1, Maureen Campion1
1Division of Geographic Medicine & Infectious Disease, Tufts Medical Center, Boston, MA, USA.
Abstract:
We surveyed SHEA Research Network institutions in the U.S. to characterize penicillin allergy delabeling practices. Although most institutions reported active delabeling programs, we found substantial variability in these initiatives. Reported barriers included minimal electronic health record (EHR) integration and time constraints. Expanding non-allergist-led programs and EHR integration are critical to optimizing and advancing delabeling.
Related Concept Videos
Cross-reactivity
Allergic Reactions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Clinical Significance of Antibiotic Resistance

